Related Experiment Video
Updated: Jun 2, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response
Xiaoyong Fu1, Catherine Huang, Rachel Schiff
1Lester and Sue Smith Breast Center, Baylor College of Medicine, One Baylor Plaza, BCM600, Houston, TX 77030, USA.
Abstract:
Estrogen receptor α (ER) is a major driver of breast cancer and the target of endocrine therapy. Full disclosure of the cofactors regulating ER interactions with chromatin and its transcriptional regulatory activity is still elusive. Novel genome-wide profiling tools have mapped ER binding events in breast cancer cells and delineated cofactors important in ER activity. Among these, the Forkhead protein FOXA1 is emerging as a key factor dictating global chromatin structure and the transcriptional function of ER in breast and non-breast cancer cells. The significance of FOXA1 in the chromatin interactions and transcriptional regulation of both estrogen- and tamoxifen-bound ER, and in supporting tamoxifen-resistant cell growth, may impact current endocrine therapies.
Insights
Forkhead protein FOXA1 is crucial for estrogen receptor alpha (ER) function in breast cancer. Understanding FOXA1
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Estrogen receptor alpha (ER) drives breast cancer and is a target for endocrine therapy.
- Cofactors regulating ER's interaction with chromatin and transcriptional activity are not fully understood.
- Novel genome-wide profiling tools are advancing the understanding of ER binding and cofactor importance.
Purpose of the Study:
- To investigate the role of Forkhead protein FOXA1 in regulating ER activity.
- To determine FOXA1's significance in ER's chromatin interactions and transcriptional regulation.
- To assess FOXA1's impact on tamoxifen-resistant breast cancer cell growth.
Main Methods:
- Utilized novel genome-wide profiling tools to map ER binding events in breast cancer cells.
- Identified and delineated key cofactors involved in ER transcriptional activity.
- Focused on the Forkhead protein FOXA1 as a potential key regulator.
Main Results:
- FOXA1 is identified as a key factor influencing global chromatin structure and ER transcriptional function.
- FOXA1 plays a significant role in the chromatin interactions of both estrogen- and tamoxifen-bound ER.
- FOXA1 supports tamoxifen-resistant breast cancer cell growth.
Conclusions:
- FOXA1 is a critical cofactor for estrogen receptor alpha in breast cancer.
- FOXA1's role in ER regulation and tamoxifen resistance has implications for endocrine therapies.
- Further research into FOXA1 may lead to improved breast cancer treatment strategies.
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Endocrine Signaling
Endocrine Signaling
An Overview of the Endocrine System
The endocrine system collaborates...
Structures of the Endocrine System

